iPSCs are a critical starting material and enable the availability of nextgeneration cell therapies for broad patient populations. Learn more about Catalent’s GMP iPSC capabilities including reprogramming, differentiation, and cell banking, and how they can create a path to make cell therapies more accessible

Catalent. More products. Better treatments. Reliably supplied.™

Every molecule has a challenge.
We have a solution.

Contact Us: catalent.com/contactus
Call: +1 888 SOLUTION
Visit: catalent.com